Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 3
2016 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Pregnancy and contraceptive use among women participating in the FEM-PrEP trial.
Callahan R, Nanda K, Kapiga S, Malahleha M, Mandala J, Ogada T, Van Damme L, Taylor D; FEM-PrEP Study Group. Callahan R, et al. J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):196-203. doi: 10.1097/QAI.0000000000000413. J Acquir Immune Defic Syndr. 2015. PMID: 25590272
BACKGROUND: Pregnancy among study participants remains a challenge for trials of new HIV prevention agents despite promotion and provision of contraception. We evaluated contraceptive use, pregnancy incidence, and study drug adhere …
BACKGROUND: Pregnancy among study participants remains a challenge for trials of new HIV prevention agents despi …
Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial.
Nanda K, Callahan R, Taylor D, Wang M, Agot K, Jenkins D, Van Damme L, Dorflinger L; FEM-PrEP Study Group. Nanda K, et al. Contraception. 2016 Jul;94(1):40-7. doi: 10.1016/j.contraception.2016.03.003. Epub 2016 Mar 10. Contraception. 2016. PMID: 26972780 Free PMC article. Clinical Trial.
OBJECTIVE: To describe medroxyprogesterone acetate (MPA) levels among Kenyan depot medroxyprogesterone acetate (DMPA) users in the FEM-PrEP HIV prevention trial, and to compare MPA levels between ARV for HIV prevention (treatment) and placebo groups. STUDY DE …
OBJECTIVE: To describe medroxyprogesterone acetate (MPA) levels among Kenyan depot medroxyprogesterone acetate (DMPA) users in the FEM …
Identifying factors that influence pregnancy intentions: evidence from South Africa and Malawi.
Evens E, Tolley E, Headley J, McCarraher DR, Hartmann M, Mtimkulu VT, Manenzhe KN, Hamela G, Zulu F; Fem-PrEP Sbc Preparedness Research Groups In South Africa And Malawi. Evens E, et al. Cult Health Sex. 2015;17(3):374-89. doi: 10.1080/13691058.2014.968806. Epub 2014 Oct 29. Cult Health Sex. 2015. PMID: 25353696
Conducted in Malawi and South Africa, this study identified individual, partner and societal factors that influence desire for pregnancy, and women's ability to achieve their intentions. Data come from interviews and focus-group discussions conducted prior to …
Conducted in Malawi and South Africa, this study identified individual, partner and societal factors that influence desire for pregnancy …
Sino-implant (II)® continuation and effect of concomitant tenofovir disoproxil fumarate-emtricitabine use on plasma levonorgestrel concentrations among women in Bondo, Kenya.
Todd CS, Deese J, Wang M, Hubacher D, Steiner MJ, Otunga S, Van Damme L; FEM-PrEP Study Group. Todd CS, et al. Contraception. 2015 Mar;91(3):248-52. doi: 10.1016/j.contraception.2014.10.008. Epub 2014 Oct 22. Contraception. 2015. PMID: 25459097 Clinical Trial.
OBJECTIVE: The objective was to assess associations between tenofovir disoproxil fumarate-emtricitabine (TDF-FTC) exposure and levonorgestrel (LNG) concentrations among Kenyan HIV prevention trial participants using Sino-implant (II) LNG implants for contraceptio …
OBJECTIVE: The objective was to assess associations between tenofovir disoproxil fumarate-emtricitabine (TDF-FTC) exposure and levonorgestre …